| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2003-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d39e184e357c2c8ccfbb0da9d43d1b33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36de568394a2264a2634937b3cc6082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e4485bddc5467b0ab4e33f861296004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8cfd249b9ba0b13e67fa4367b92d0fa |
| publicationDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004038883-A1 |
| titleOfInvention |
Peptide inhibitors of Akt and uses thereof |
| abstract |
The subject invention relates to peptide inhibitors of Akt as well as to uses of these inhibitors. More specifically, the inhibitors may be used, for example, to induce apoptosis in cells and sensitize tumor cells to cancer therapies. The peptides may also be used to purify Akt. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008015841-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029008-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029008-A2 |
| priorityDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |